Supporter Stewardship Executive
Role Focus Areas
Supporter Stewardship Data Management and Reporting Prospecting
Details
Location: Hybrid - 1 day/week in London Bridge Office
Annual Salary: £26,963 pro rata
Hours: Part-time (21 hours a week)
Contract: Permanent (6 month probationary period)
Start Date: ASAP
Reporting to: Head of Fundraising and Communications
Job Outline
Neuroblastoma UK are seeking a highly organised, responsible and proactive professional to support the team in delivering top tier stewardship to supporters and support income growth in our small team of 3 staff, closely supported by a volunteer trustee board.
Someone who has excellent attention to detail, enjoys building relationships, and who always strives to ensure tasks are performed to the highest level, would thrive in this role.
Key Responsibilities
Deliver warm supporter stewardship to fundraisers including making welcome calls, collating and posting out fundraising packs and attending fundraising events.
Handle supporter enquiries via email and telephone
Keep accurate data records of engagement, donations and fundraising
Produce reports on supporter trends, and identify prospects to support growth
Manage delivery of key challenge events including the London Marathon
Own Fundraising Event Calendar - collaborating with Communications Officer on planning and drafting marketing
Support the Senior Communications Officer and Head of Fundraising and Communications in the delivery of all fundraising and communications activations; including in-memory fundraising, legacy and lottery.
Fulfill shop orders managing inventory and updating stock levels
Any other duties that working in a small organisations requires
Person specification
Highly personable with the ability to develop warm relationships
Responsible and organised
Excellent phone manner, including sensitivity towards issues such as illness and bereavement
Excellent written communication skills
Collaborative and willing to lend their support where most needed
Commitment to our mission to find better treatment and a cure for children facing neuroblastoma